folic acid has been researched along with Carcinoma, Non-Small Cell Lung in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.85) | 18.2507 |
2000's | 13 (24.07) | 29.6817 |
2010's | 26 (48.15) | 24.3611 |
2020's | 14 (25.93) | 2.80 |
Authors | Studies |
---|---|
Chen, D; Hu, Y; Low, PS; Napoleon, JV; Savran, CA; Singhal, S; Srinivasarao, M | 1 |
Chen, J; Huang, L; Li, X; Lin, J; Tu, Y; Zheng, R | 1 |
Ahlawat, P; Bal, A; Phutela, K; Sharma, S; Singh, N | 1 |
Baudouin, A; Beaurain, M; Couraud, S; Herledan, C; Ranchon, F; Rioufol, C; Souquet, PJ; Teixeira, A; Vantard, N | 1 |
El-Brolsy, HMEM; El-Kemary, MA; Hanafy, NAN | 1 |
Chen, JS; Chen, TE; Chen, YC; Cheng, ML; Huang, RS; Lin, YS; Lynn, KS; Shah, P | 1 |
Buddolla, V; Kim, YJ; Lakshmi, BA; Varaganti, P | 1 |
Hashimoto, M; Hirano, S; Katsuya, Y; Kobayashi, K; Naka, G; Suzuki, M; Takeda, Y; Uemura, Y | 1 |
Bhosle, J; Gunapala, R; Hodgkiss, A; Kumar, R; Mak, D; Minchom, A; O'Brien, MER; Popat, S; Walder, D; Yousaf, N | 1 |
Ai, Y; Du, X; Song, Y; Wang, Y; Xia, Z; Zhang, J; Zhao, G; Zhou, B | 1 |
Banerjee, S; Banerji, U; Cojocaru, E; Scaranti, M | 1 |
Feng, H; Li, G; Liu, Y; Tan, G; Wang, Y; Xing, W; Xu, Z | 1 |
Badanthadka, M; Chokshi, N; Khatri, H; Patel, BM; Patel, MM; Rawal, S | 1 |
Aydin, C; Esendagli, G; Karpuz, M; Ozer, AY; Ozturk, SC; Silindir-Gunay, M; Tuncel, M; Yanik, H | 1 |
Chang, YC; Chou, YT; Ho, CT; Hsiao, SH; Liu, JJ; Shen, PW | 1 |
Kasinski, AL; Low, PS; Lyle, LT; Orellana, EA; Rangasamy, L; Tenneti, S | 1 |
Alnatsha, A; Calleja-Hernández, MÁ; Cañadas-Garre, M; Faus-Dáder, MJ; Pérez-Ramírez, C; Valdivia-Bautista, J; Villar, E | 1 |
Chang, GC; Chiu, LY; Hsu, SL; Huang, YR; Sheu, GT; Yang, TY | 1 |
Belinsky, SA; Bruse, SE; Flores, KG; Gauderman, WJ; Gilliland, FD; Leng, S; Liu, Y; Picchi, MA; Stidley, CA; Thomas, CL; Van Den Berg, D; Zhang, X | 1 |
Caddick, S; Cal, PM; Chudasama, V; Cordeiro, C; Frade, RF; Gois, PM | 1 |
Bacus, SS; Moran, DM; Paz, K; Pry, K; Sidransky, D; Trusk, PB | 1 |
Aggarwal, AN; Behera, D; Kaur, J; Singh, N | 1 |
Hosomi, Y; Iguchi, M; Nagamata, M; Nakahara, Y; Okamoto, H; Okamura, T; Okuma, Y; Shibuya, M; Shimokawa, T; Sunami, K; Takagi, Y; Yomota, M | 1 |
Horai, T; Horiike, A; Kudo, K; Nishio, M; Ohyanagi, F; Saito, R; Sakatani, T; Tanaka, H; Yanagitani, N | 1 |
Chohnabayashi, N; Gotoh, K; Jinta, T; Kitamura, A; Koyama, K; Nishimura, N; Ohde, S; Okafuji, K; Takayama, S; Tomishima, Y; Tsuda, Y; Yagi, N | 1 |
Behera, D; Maturu, VN; Singh, N | 1 |
Hosomi, Y; Okamoto, H; Shibuya, M; Takagi, Y | 1 |
Berezowska, S; Dorn, P; Froment, L; Hall, SR; Kocher, G; Liang, SQ; Marti, TM; Peng, RW; Schmid, RA | 1 |
He, Z; Huang, C; Huang, J; Sun, W; Teng, Y; Wu, Y; Xu, Y; Zhang, H; Zhang, X | 1 |
Chen, W; He, Z; Huang, J; Ma, J; Shi, Z; Sun, W; Xia, J; Zhang, X | 1 |
Hosomi, Y; Nagamata, M; Nakahara, Y; Okamura, T; Okuma, Y; Shimokawa, T; Sunami, K; Takagi, Y; Takahashi, S; Watanabe, K; Yomota, M | 1 |
Aggarwal, C; Alley, EW; Bagley, SJ; Blair, IA; Cohen, RB; Evans, TL; Langer, CJ; Vachani, A; Vitale, S; Whitehead, AS; Zhang, S | 1 |
Hu, LL; Li, ZP; Liu, J; Wang, AW; Wang, ZD; Zhao, QS | 1 |
Baldi, M; Behera, D; Kapoor, R; Kaur, J; Singh, N | 1 |
Banerjee, T; Heckert, B; Kallu, J; Naz, S; Santra, S; Shelby, T; Sulthana, S; Vuppala, SR; Yambem, O | 1 |
Adachi, S; Fujimoto, T; Fukuoka, M; Ichinose, Y; Kubota, K; Nakagawa, K; Nambu, Y; Nishiwaki, Y; Ohe, Y; Saijo, N; Tamura, T; Yamamoto, N | 1 |
Bearz, A; Pampaloni, G; Russo, F | 1 |
Fukui, Y; Jin, M; Kawakami, K; Minamoto, T; Oda, M; Oka, T; Takechi, T; Tsukioka, S; Watanabe, G | 1 |
Bosch-Barrera, J; Ceballos, J; Ferrer, M; García-Foncillas, J; Gaztañaga, M; Gil-Bazo, I; Idoate, MA; López-Picazo, JM; Pérez-Gracia, JL; Pretel, M; Sanz, ML | 1 |
Barata, F; Barlesi, F; Bearz, A; Bepler, G; Chiappori, A; Chouaki, N; Iscoe, N; Liepa, AM; Park, K; Reck, M; Scagliotti, G; Soria, JC; von Pawel, J; Wagle, A; Zhao, YD | 1 |
Azzoli, CG; Dunne, M; Ginsberg, M; Huntington, M; James, L; Kris, MG; Krug, LM; May, J; Miller, V; Patel, JD; Saunders, M; Sirotnak, FM; Subzwari, S; Tyson, L | 1 |
Desmoulin, SK; Gangjee, A; Hou, Z; Matherly, LH | 1 |
Igawa, S; Katono, K; Maki, S; Masuda, N; Otani, S; Ryuge, S; Sasaki, J; Sato, Y; Takakura, A; Wada, M | 1 |
Hassan, R; Maltzman, J; Thomas, A | 1 |
Adjei, AA | 1 |
Budde, LS; Hanna, NH | 1 |
Scagliotti, GV | 1 |
Bridle, H; Eisen, T; El Galta, R; Houlston, RS; Matakidou, A; Rudd, MF; Webb, EL | 1 |
Chattopadhyay, S; Goldman, ID; Min, SH; Tamari, R; Tsai, E; Zhao, R | 1 |
Clarke, SJ; Li, KM; Rivory, LP | 1 |
Daly, BD; Jatoi, A; Kramer, G; Mason, JB | 2 |
Backus, HH; Jansen, G; Molders, N; Padrón, JM; Peters, GJ; Pinedo, HM; van Der Wilt, CL; van Groeningen, CJ; Wouters, D | 1 |
Bunn, PA | 1 |
7 review(s) available for folic acid and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Recent advances in using folate receptor 1 (FOLR1) for cancer diagnosis and treatment, with an emphasis on cancers that affect women.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Folate Receptor 1; Folic Acid; Humans; Lung Neoplasms; Ovarian Neoplasms | 2023 |
Exploiting the folate receptor α in oncology.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Endometrial Neoplasms; Female; Fluorescent Dyes; Folate Receptor 1; Folic Acid; Folic Acid Antagonists; Humans; Immunoconjugates; Immunologic Factors; Immunotherapy, Adoptive; Lung Neoplasms; Maytansine; Mesothelioma; Molecular Imaging; Molecular Targeted Therapy; Neoplasms; Optical Imaging; Ovarian Neoplasms; Radionuclide Imaging; Theranostic Nanomedicine; Tubulin Modulators | 2020 |
The human proton-coupled folate transporter: Biology and therapeutic applications to cancer.
Topics: Biological Transport; Carcinoma, Non-Small-Cell Lung; Folic Acid; Folic Acid Antagonists; Glutamates; Guanine; Humans; Lung Neoplasms; Mesothelioma; Molecular Targeted Therapy; Neoplasms; Pemetrexed; Proton-Coupled Folate Transporter | 2012 |
Farletuzumab in lung cancer.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Folate Receptor 1; Folic Acid; Humans; Lung Neoplasms | 2013 |
Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Folic Acid; Glutamates; Guanine; Humans; Lung Neoplasms; Neoplasms; Pemetrexed; Platinum Compounds; Thymidylate Synthase; Vitamin B 12 | 2004 |
Antimetabolites in the management of non-small cell lung cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Folic Acid; Glutamates; Guanine; Humans; Lung Neoplasms; Pemetrexed; Survival; Treatment Outcome | 2005 |
Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Folic Acid; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Mesothelioma; Pemetrexed; Pleural Neoplasms; Thymidylate Synthase; Vitamin B 12 | 2002 |
8 trial(s) available for folic acid and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
A prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Folic Acid; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pemetrexed; Prospective Studies; Treatment Outcome; Vitamin B 12 | 2014 |
Phase II study of oral vitamin B12 supplementation as an alternative to intramuscular injection for patients with non-small cell lung cancer undergoing pemetrexed therapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Folic Acid; Homocysteine; Humans; Lung Neoplasms; Male; Middle Aged; Pemetrexed; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B Complex | 2016 |
Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non-Small-cell Lung Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Erythrocytes; Female; Folic Acid; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pemetrexed; Prognosis; Prospective Studies; Survival Rate; Vitamin B Complex | 2017 |
Rationale and Design of PEMVITASTART-An Open-label Randomized Trial Comparing Simultaneous Versus Standard Initiation of Vitamin B
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Dietary Supplements; Female; Folic Acid; Humans; Lung Neoplasms; Male; Middle Aged; Patient Selection; Pemetrexed; Prospective Studies; Research Design; Treatment Outcome; Vitamin B 12; Young Adult | 2017 |
Efficacy and safety of two doses of pemetrexed supplemented with folic acid and vitamin B12 in previously treated patients with non-small cell lung cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Female; Folic Acid; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Pemetrexed; Regression Analysis; Safety; Treatment Outcome; Vitamin B 12 | 2008 |
Phase II, double-blinded, randomized study of enzastaurin plus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Double-Blind Method; Female; Folic Acid; Glutamates; Guanine; Humans; Indoles; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Pemetrexed; Prognosis; Salvage Therapy; Survival Rate; Vitamin B 12 | 2010 |
Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: safety and efficacy in a phase 1 trial.
Topics: Adenocarcinoma; Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Dietary Supplements; Female; Folic Acid; Folic Acid Antagonists; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Prognosis; Tissue Distribution; Vitamin B 12; Vitamin B Complex | 2011 |
Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Deoxyuridine; Dietary Supplements; Dose-Response Relationship, Drug; Female; Folic Acid; Glutamates; Guanine; Homocysteine; Humans; Lung Neoplasms; Male; Methylmalonic Acid; Middle Aged; Pemetrexed; Thymidine; Thymidylate Synthase; Vinblastine; Vinorelbine; Vitamin B 12 | 2007 |
39 other study(ies) available for folic acid and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Efficient capture of circulating tumor cells with low molecular weight folate receptor-specific ligands.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Count; Cell Line, Tumor; Cell Separation; Folic Acid; Humans; Ligands; Lung Neoplasms; Mice; Molecular Weight; Neoplastic Cells, Circulating | 2022 |
Folic acid-mediated MSNs@Ag@Geb multifunctional nanocomposite heterogeneous platform for combined therapy of non-small cell lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Doxorubicin; Folic Acid; Gefitinib; Humans; Lung Neoplasms; Manganese Compounds; Metal Nanoparticles; Nanocomposites; Nanoparticles; Oxides; Silicon Dioxide; Silver | 2022 |
Therapeutic potential of human serum albumin nanoparticles encapsulated actinonin in murine model of lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease Models, Animal; Folic Acid; Humans; Hydroxamic Acids; Lung Neoplasms; Mice; Nanoparticles; Serum Albumin, Human | 2022 |
Intravenous route for folate supplementation in a patient with celiac disease treated by pemetrexed-based chemotherapy for non-small-cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Celiac Disease; Dietary Supplements; Folic Acid; Humans; Injections, Intravenous; Levoleucovorin; Lung Neoplasms; Pemetrexed | 2023 |
Fighting Non-Small Lung Cancer Cells Using Optimal Functionalization of Targeted Carbon Quantum Dots Derived from Natural Sources Might Provide Potential Therapeutic and Cancer Bio Image Strategies.
Topics: Carbon; Carcinoma, Non-Small-Cell Lung; Folic Acid; Humans; Lung Neoplasms; Microscopy, Fluorescence; Quantum Dots | 2022 |
Probing Folate-Responsive and Stage-Sensitive Metabolomics and Transcriptional Co-Expression Network Markers to Predict Prognosis of Non-Small Cell Lung Cancer Patients.
Topics: Amino Acid Transport System ASC; Carcinoma, Non-Small-Cell Lung; Folic Acid; Glutamine; Humans; Lung Neoplasms; Metabolomics; Minor Histocompatibility Antigens; Prognosis; Tandem Mass Spectrometry | 2022 |
Correlation of toxicities and efficacies of pemetrexed with clinical factors and single-nucleotide polymorphisms: a prospective observational study.
Topics: Carcinoma, Non-Small-Cell Lung; Folic Acid; Humans; Lung Neoplasms; Mesothelioma, Malignant; Pemetrexed; Polymorphism, Single Nucleotide | 2023 |
A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Carcinoma, Non-Small-Cell Lung; Depression; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pemetrexed; Prospective Studies; Treatment Outcome; Vitamin B 12; Vitamins | 2019 |
Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Drug Liberation; Drug Synergism; Female; Flavonoids; Folic Acid; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Multidrug Resistance-Associated Proteins; Nanoparticles; Poly (ADP-Ribose) Polymerase-1; Rats; RNA, Small Interfering | 2020 |
[Preliminary Study on Detection of Circulating Tumor Cells in Lung Cancer by EGFR/Vimentin/Folic Acid Magnetic Sphere].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Folic Acid; Humans; Immunomagnetic Separation; Magnetic Phenomena; Male; Middle Aged; Neoplastic Cells, Circulating; Vimentin | 2020 |
Fabrication and in vivo evaluation of ligand appended paclitaxel and artemether loaded lipid nanoparticulate systems for the treatment of NSCLC: A nanoparticle assisted combination oncotherapy.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Artemether; Biological Availability; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Folic Acid; Humans; Lipids; Lung Neoplasms; Male; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Polyethylene Glycols; Rats, Sprague-Dawley; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
Diagnostic and therapeutic evaluation of folate-targeted paclitaxel and vinorelbine encapsulating theranostic liposomes for non-small cell lung cancer.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Folic Acid; Liposomes; Lung Neoplasms; Mice; Mice, Inbred C57BL; Paclitaxel; Precision Medicine; Tissue Distribution; Vinorelbine | 2021 |
Disruption of Cytosolic Folate Integrity Aggravates Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Modulates Metastatic Properties in Non-Small-Cell Lung Cancer Cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Cytoplasm; Drug Resistance, Neoplasm; ErbB Receptors; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Tumor Cells, Cultured | 2021 |
FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer.
Topics: A549 Cells; Animals; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Folic Acid; Gene Targeting; Gene Transfer Techniques; Humans; Immunocompetence; Ligands; Lung Neoplasms; Mice; MicroRNAs; Proto-Oncogene Proteins p21(ras); Xenograft Model Antitumor Assays | 2017 |
Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; DNA Repair; DNA-Binding Proteins; Endonucleases; Female; Folic Acid; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Pharmacogenetics; Platinum; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins c-mdm2; Reduced Folate Carrier Protein; Survival Analysis; X-ray Repair Cross Complementing Protein 1; Xeroderma Pigmentosum Group D Protein | 2019 |
Effect of folic acid and vitamin B12 on pemetrexed antifolate chemotherapy in nutrient lung cancer cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dietary Supplements; Drug Screening Assays, Antitumor; Fluorouracil; Folic Acid; Folic Acid Antagonists; G1 Phase; Glutamates; Guanine; Humans; Lung Neoplasms; Neoplasm Proteins; Pemetrexed; Protein Stability; Serum; Treatment Outcome; Vitamin B 12 | 2013 |
Native American ancestry affects the risk for gene methylation in the lungs of Hispanic smokers from New Mexico.
Topics: Aged; American Indian or Alaska Native; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Diet; DNA Methylation; Female; Folic Acid; Hispanic or Latino; Humans; Longitudinal Studies; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; New Mexico; Promoter Regions, Genetic; Risk Factors; Smoking; Sputum | 2013 |
Targeting cancer cells with folic acid-iminoboronate fluorescent conjugates.
Topics: Benzene Derivatives; Boronic Acids; Carcinoma, Non-Small-Cell Lung; Endocytosis; Fluorescent Dyes; Folate Receptor 1; Folic Acid; Humans; Lung Neoplasms; Molecular Structure; Muramidase; Tumor Cells, Cultured | 2014 |
KRAS mutation status is associated with enhanced dependency on folate metabolism pathways in non-small cell lung cancer cells.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Methylenetetrahydrofolate Dehydrogenase (NADP); Mice; Mutation; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Xenograft Model Antitumor Assays | 2014 |
Association of Graded Folic Acid Supplementation and Total Plasma Homocysteine Levels With Hematological Toxicity During First-line Treatment of Nonsquamous NSCLC Patients With Pemetrexed-based Chemotherapy.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Interactions; Drug Therapy, Combination; Female; Folic Acid; Hematinics; Homocysteine; Humans; Lung Neoplasms; Male; Middle Aged; Pemetrexed; Retrospective Studies | 2017 |
Plasma homocysteine levels and hematological toxicity in NSCLC patients after the first cycle of pemetrexed under folate supplementation.
Topics: Adult; Aged; Antineoplastic Agents; Blood Platelets; Carcinoma, Non-Small-Cell Lung; Female; Folic Acid; Glutamates; Guanine; Homocysteine; Humans; Leukocytes; Lung Neoplasms; Male; Middle Aged; Pemetrexed | 2015 |
[Safety of pemetrexed according to the duration of vitamin B12 and folic acid supplementation prior to the first dose of pemetrexed].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Diarrhea; Dietary Supplements; Drug Combinations; Exanthema; Female; Folic Acid; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pemetrexed; Retrospective Studies; Vitamin B 12 | 2015 |
Total Plasma Homocysteine Level Assessment and Timing of Folate/B12 Supplementation Prior to Initiation of Pemetrexed-Based Chemotherapy for Nonsquamous Non-Small Cell Lung Cancer Patients: An Irrelevant Investigation, an Unnecessary Delay, or Both?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Folic Acid; Humans; Lung Neoplasms; Male; Vitamin B 12 | 2015 |
In Reply.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Folic Acid; Humans; Lung Neoplasms; Male; Vitamin B 12 | 2015 |
Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Folic Acid; Folic Acid Antagonists; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Signal Transduction | 2015 |
Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Delivery Systems; Folic Acid; Humans; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Paclitaxel; Polyesters; Polyethylene Glycols; Tissue Distribution; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blood; Blood Coagulation; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line; Cisplatin; Complement Activation; Drug Carriers; Drug Compounding; Folic Acid; Hemolysis; Humans; Leukocyte Count; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Polyesters; Polyethylene Glycols; Rabbits; Xenograft Model Antitumor Assays | 2016 |
Resveratrol-loaded folic acid-grafted dextran stearate submicron particles exhibits enhanced antitumor efficacy in non-small cell lung cancers.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Caspase 3; Dextrans; Drug Liberation; Folic Acid; Humans; Lung Neoplasms; Mitochondria; Particle Size; Resveratrol; Stilbenes; Tumor Suppressor Protein p53 | 2017 |
Combination Therapy of NSCLC Using Hsp90 Inhibitor and Doxorubicin Carrying Functional Nanoceria.
Topics: A549 Cells; Acrylic Resins; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cerium; Combined Modality Therapy; Doxorubicin; Drug Carriers; Folic Acid; HSP90 Heat-Shock Proteins; Humans; Lung Neoplasms; Nanoparticles; Rats; Reactive Oxygen Species; Triazoles | 2017 |
Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dexamethasone; Female; Folic Acid; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pemetrexed; Vitamin B 12 | 2008 |
Different histological types of non-small cell lung cancer have distinct folate and DNA methylation levels.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cadherins; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Core Binding Factor Alpha 3 Subunit; DNA Methylation; Female; Folic Acid; Humans; Immunohistochemistry; Long Interspersed Nucleotide Elements; Lung Neoplasms; Male; Middle Aged | 2009 |
Toxic epidermal necrolysis related to pemetrexed and carboplatin with vitamin B12 and folic acid supplementation for advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Folic Acid; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Pemetrexed; Stevens-Johnson Syndrome; Vitamin B 12 | 2009 |
Pemetrexed for previously treated patients with non-small cell lung cancer and differences in efficacy according to thymidylate synthase expression.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Folic Acid; Glutamates; Guanine; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Pemetrexed; Salvage Therapy; Thrombocytopenia; Thymidylate Synthase; Treatment Outcome | 2012 |
Pemetrexed: a new cytotoxic agent in the development for first-line non-small-cell lung cancer.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Dietary Supplements; Folic Acid; Folic Acid Antagonists; Glutamates; Guanine; Humans; Lung Neoplasms; Pemetrexed; Vitamin B 12 | 2005 |
Prognostic significance of folate metabolism polymorphisms for lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Enzymes; Female; Folic Acid; Genotype; Humans; Lung Neoplasms; Metabolic Networks and Pathways; Polymorphism, Single Nucleotide; Prognosis | 2007 |
Commentary: a case for minimizing folate supplementation in clinical regimens with pemetrexed based on the marked sensitivity of the drug to folate availability.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Colorectal Neoplasms; Folic Acid; Folic Acid Antagonists; Glutamates; Guanine; Humans; In Vitro Techniques; Lung Neoplasms; Mesothelioma; Pemetrexed; Tetrahydrofolates | 2007 |
A cross-sectional study of vitamin intake in postoperative non-small cell lung cancer patients.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cross-Sectional Studies; Dietary Supplements; Disease-Free Survival; Erythrocytes; Female; Folic Acid; Humans; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Postoperative Care; Vitamin A | 1998 |
Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carrier Proteins; Colonic Neoplasms; Fluorouracil; Folic Acid; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Leucovorin; Lung Neoplasms; Membrane Proteins; Membrane Transport Proteins; Mice; Multienzyme Complexes; Neoplasms; Peptide Synthases; Reduced Folate Carrier Protein; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; Tumor Cells, Cultured | 2000 |
Folate status among patients with non-small cell lung cancer: a case-control study.
Topics: Aged; Alcohol Drinking; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Diet; Female; Folic Acid; Homocystine; Humans; Lung Neoplasms; Male; Postoperative Period; Risk Factors; Smoking | 2001 |